The global life sciences ecosystem is registering intensive consolidation momentum as Massachusetts-based Lantheus Holdings considers a multi-billion-dollar takeover proposal from... Read more
Tag: #M&A
Tasco Pharma deploys over 200 billion VND to anchor major stake in Pharmedic amid eye drop product recall
The equity ownership architecture of Pharmedic Pharmaceutical Medicinal Joint Stock Company (Ticker: PMC) has undergone a major transition, with Tasco... Read more
Lantheus evaluates potential $7 billion buyout following acquisition proposal from Curium
Radiopharmaceutical specialist Lantheus Holdings is currently weighing a potential sale of the company after receiving a strategic takeover bid from... Read more
Jardine Matheson enters Australian healthcare sector via $2.4 billion acquisition of I-MED Radiology
Hong Kong-based multinational conglomerate Jardine Matheson has announced a definitive agreement to purchase a 100% equity stake in I-MED Radiology... Read more
Gilead Sciences expands oncology portfolio via $5 billion acquisition of Tubulis
Biopharmaceutical multinational Gilead Sciences has finalized the corporate acquisition of Tubulis GmbH, a privately held, Germany-based biotech entity operating at... Read more
Eli Lilly absorbs Engage Biologics to secure proprietary non-viral DNA delivery platform
Pharmaceutical giant Eli Lilly has finalized a definitive agreement to acquire the seed-funded biotechnology startup Engage Biologics Inc. to strengthen... Read more
Global Healthcare Opportunities and CBC Group align to forge world’s largest healthcare investment entity
One of Europe’s premier healthcare-focused private equity firms, Global Healthcare Opportunities (GHO), and Asia's prominent CBC Group are merging operations... Read more
Pillr Health acquires CaptureRx to expand its federal pharmacy infrastructure footprint
Pillr Health has finalized the acquisition of San Antonio-based administrative specialist CaptureRx, effectively broadening its operational scale and federal 340B... Read more
Biogen Completes Strategic Acquisition of Apellis Pharmaceuticals
On May 14, 2026, Biogen Inc. announced the successful completion of its acquisition of Apellis Pharmaceuticals, Inc., which is now... Read more









